Business

A $480,000-a-Year Pill Reflects aNew Normal for Cancer Drugs

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.

This story summarizes reporting from The New York Times. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.

Read full story on The New York Times →

Rebecca Robbins31 Aug 2026, 04:43 pmUpdated 1d ago1 min readBusinessGlobal

Global — Rebecca Robbins

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.

This report is published with credit to The New York Times. The wire sent a summary; open the original for any extra context. Read on The New York Times →

Source: The New York Times · Rebecca Robbins. Published 31 Aug 2026, 04:43 pm.

Next news → Two More Oil Tankers Are Attacked in the S…Browse more stories